Home/Filings/4/0001415889-24-019344
4//SEC Filing

Cappello Joseph 4

Accession 0001415889-24-019344

CIK 0001231457other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 4:30 PM ET

Size

6.6 KB

Accession

0001415889-24-019344

Insider Transaction Report

Form 4
Period: 2024-02-19
Cappello Joseph
VP, Pharmaceutical Development
Transactions
  • Award

    Common Stock

    2024-02-19+3,6619,396 total
  • Award

    Common Stock

    2024-03-14+11,55720,953 total
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024.
  • [F2]Represents RSUs that are fully vested as of March 14, 2024.

Issuer

GENELUX Corp

CIK 0001231457

Entity typeother

Related Parties

1
  • filerCIK 0001939198

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:30 PM ET
Size
6.6 KB